ESC 365 - Welcome and introduction: the origin and evolution of the disease.

Open Access

Welcome and introduction: the origin and evolution of the disease.

Session: New targets to enhance survival and outcomes in hATTR amyloidosis

Topic: Clinical

Speaker: Professor T. Damy (Creteil, FR)

Sponsored by Alnylam Pharmaceuticals

Event: Heart Failure 2022

Congress Presentation

About the speaker

Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

28 presentations

1 follower

3 more presentations in this session

Treatment strategies targeting TTR amyloid in hATTR amyloidosis (a multi-system disease).

Speaker: Doctor H. Nienhuis (Groningen, NL)

Update on RNAi therapy in hATTR amyloidosis.

Speaker: Doctor P. Garcia-Pavia (Majadahonda, Madrid, ES)

Discussion and closing remarks.

Speaker: Professor T. Damy (Creteil, FR) Doctor H. Nienhuis (Groningen, NL) Doctor P. Garcia-Pavia (Majadahonda, Madrid, ES)

Access the full session

New targets to enhance survival and outcomes in hATTR amyloidosis

Speakers: Professor T. Damy, Doctor H. Nienhuis, Doctor P. Garcia-Pavia, Professor T. Damy, Doctor H. Nienhuis...

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by